HRP20161465T8 - Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo - Google Patents

Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Info

Publication number
HRP20161465T8
HRP20161465T8 HRP20161465TT HRP20161465T HRP20161465T8 HR P20161465 T8 HRP20161465 T8 HR P20161465T8 HR P20161465T T HRP20161465T T HR P20161465TT HR P20161465 T HRP20161465 T HR P20161465T HR P20161465 T8 HRP20161465 T8 HR P20161465T8
Authority
HR
Croatia
Prior art keywords
high density
inorganic nanoparticles
density inorganic
vivo destruction
destruction
Prior art date
Application number
HRP20161465TT
Other languages
English (en)
Croatian (hr)
Inventor
Laurent Levy
Agnès Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of HRP20161465T1 publication Critical patent/HRP20161465T1/hr
Publication of HRP20161465T8 publication Critical patent/HRP20161465T8/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HRP20161465TT 2008-06-05 2009-06-04 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo HRP20161465T8 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (fr) 2008-06-05 2008-06-05 Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo
US6020208P 2008-06-10 2008-06-10
PCT/EP2009/056880 WO2009147214A2 (fr) 2008-06-05 2009-06-04 Nanoparticules inorganiques, leur préparation et leurs utilisations
EP09757595.5A EP2300054B1 (fr) 2008-06-05 2009-06-04 Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo

Publications (2)

Publication Number Publication Date
HRP20161465T1 HRP20161465T1 (hr) 2017-01-27
HRP20161465T8 true HRP20161465T8 (hr) 2017-04-21

Family

ID=39734334

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20161465TT HRP20161465T8 (hr) 2008-06-05 2009-06-04 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
HRP20181993TT HRP20181993T1 (hr) 2008-06-05 2018-11-27 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20181993TT HRP20181993T1 (hr) 2008-06-05 2018-11-27 Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo

Country Status (26)

Country Link
US (1) US8845507B2 (fr)
EP (4) EP2130553A1 (fr)
JP (1) JP5734181B2 (fr)
KR (1) KR101639281B1 (fr)
CN (1) CN102056628B (fr)
AU (1) AU2009254550B2 (fr)
BR (1) BRPI0913410B1 (fr)
CA (1) CA2727576C (fr)
CY (2) CY1118217T1 (fr)
DK (2) DK2300054T3 (fr)
EA (1) EA023012B1 (fr)
ES (2) ES2702249T3 (fr)
HR (2) HRP20161465T8 (fr)
HU (2) HUE030669T2 (fr)
IL (1) IL209625A (fr)
LT (2) LT3150227T (fr)
MA (1) MA32453B1 (fr)
MX (1) MX2010013322A (fr)
NZ (1) NZ589888A (fr)
PL (2) PL2300054T3 (fr)
PT (2) PT2300054T (fr)
SG (1) SG10201405288WA (fr)
SI (2) SI3150227T1 (fr)
TR (1) TR201819077T4 (fr)
WO (1) WO2009147214A2 (fr)
ZA (1) ZA201100082B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075975A2 (fr) * 2003-02-24 2004-09-10 Pomper Mark E Vehicule de radiotherapie mobile et methode associee
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
EP2275137A1 (fr) * 2009-07-10 2011-01-19 Nanobiotix Nanoparticules métalliques, leur préparation et utilisations
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
WO2011060033A1 (fr) 2009-11-10 2011-05-19 Immunolight, L.L.C. Systèmes de conversion supérieure et inférieure pour la production de lumière émise à partir de différentes sources d'énergie, comprenant des sources à haute fréquence, des sources d'énergie à micro-ondes et des sources à induction magnétique pour la conversion supérieure
CN105931696B (zh) 2010-04-23 2017-07-07 皮瑟莱根特科技有限责任公司 纳米晶体的合成、盖帽和分散
US8920675B2 (en) 2010-10-27 2014-12-30 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
BR112014014412A2 (pt) 2011-12-16 2017-06-13 Nanobiotix nanopartículas compreendendo materiais metálicos e de óxido de háfnio, sua preparação e uso
CA2874761A1 (fr) * 2012-06-14 2013-12-19 Board Of Trustees Of The University Of Arkansas Compositions et procedes pour une detection et un traitement non invasifs de cellules hypoxiques in vivo
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
KR102385193B1 (ko) * 2013-01-25 2022-04-12 나노비오?笭? 암 치료용 이온화 방사선과 조합된 무기 나노입자 조성물
WO2014130429A2 (fr) * 2013-02-19 2014-08-28 National Health Research Institutes Nanoagrégats de platine en cage pour produits chimiothérapeutiques anticancéreux
JP6387400B2 (ja) 2013-05-30 2018-09-05 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 医薬組成物、その製造および使用
BR112015031977A2 (pt) * 2013-06-20 2017-07-25 Nanobiotix gel biocompatível, e, kit
JP6671292B2 (ja) * 2013-12-16 2020-03-25 ジェネンテック， インコーポレイテッド ペプチド模倣化合物及びその抗体−薬物コンジュゲート
EP2886128A1 (fr) * 2013-12-20 2015-06-24 Nanobiotix Compositions pharmaceutiques comportant des nanoparticules, leur préparation et leur utilisation
ES2951598T3 (es) * 2014-11-25 2023-10-23 Curadigm Sas Composición farmacéutica que combina al menos dos nanopartículas distintas y un compuesto farmacéutico, preparación y usos de los mismos
KR102666251B1 (ko) 2014-11-25 2024-05-27 큐라디즘 약학적 조성물, 이의 제조 및 용도
HK1245086A1 (zh) 2014-11-25 2018-08-24 Nanobiotix 处方药物组成及其制备和使用
WO2016083331A1 (fr) 2014-11-25 2016-06-02 Nanobiotix Composition pharmaceutique, sa préparation et ses utilisations
DK3223796T3 (da) 2014-11-25 2021-09-27 Curadigm Sas Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
US20180008733A1 (en) * 2015-01-08 2018-01-11 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
MA43100A (fr) * 2015-05-28 2018-09-05 Nanobiotix Nanoparticules à utiliser en tant que vaccin thérapeutique
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
CN115768523A (zh) * 2020-05-26 2023-03-07 纳米生物技术公司 纳米粒子、电离辐射及其创新治疗组合
JP2023549698A (ja) * 2020-11-05 2023-11-29 ナノビオティックス がんの治療のためのナノ粒子の組成物
US20240000940A1 (en) * 2020-12-01 2024-01-04 Nanobiotix S.A. Porous, high-z and carbon-free particles as radioenhancers
EP4633676A1 (fr) 2022-12-12 2025-10-22 Nanobiotix Nouvelles nanoparticules d'oxyde métallique et compositions de celles-ci destinées à être utilisées en tant que radioactivateurs ou pour visualiser un tissu biologique
EP4595983A1 (fr) 2024-02-05 2025-08-06 BXTA Nanotherapy Limited Nanoparticules fonctionnalisées avec un agent stabilisant et un agent de ciblage
WO2026074471A1 (fr) * 2024-10-02 2026-04-09 Janssen Pharmaceutica Nv Polythérapies avec des nanoparticules d'oxyde d'hafnium et des anticorps pd-l1 destinés à être utilisés dans le traitement du cancer du poumon non à petites cellules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
WO2000006244A2 (fr) 1998-07-30 2000-02-10 Hainfeld James F Particules metalliques de chargement dans des vesicules membranaires cellulaires et particule metallique utilisee pour l'imagerie et la therapie
JP2007514736A (ja) 2003-12-17 2007-06-07 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 紫外線放射ナノ粒子を用いた放射線治療および医学画像
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
WO2008007290A2 (fr) * 2006-07-10 2008-01-17 Philips Intellectual Property & Standards Gmbh nanoparticules à noyau/enveloppe à des fins de thérapie et d'imagerie
EP1920784A1 (fr) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Sensibilisateurs de radiation pour la thérapie par rayonnements ionisants et pour l'imagerie

Also Published As

Publication number Publication date
ZA201100082B (en) 2011-10-26
EP3461502A1 (fr) 2019-04-03
WO2009147214A3 (fr) 2010-02-25
NZ589888A (en) 2012-06-29
HUE040247T2 (hu) 2019-02-28
CN102056628A (zh) 2011-05-11
IL209625A0 (en) 2011-02-28
US20110213192A1 (en) 2011-09-01
PL3150227T3 (pl) 2019-05-31
TR201819077T4 (tr) 2019-01-21
BRPI0913410A2 (pt) 2015-11-24
EA201071429A1 (ru) 2011-06-30
DK3150227T3 (en) 2019-01-14
BRPI0913410B1 (pt) 2021-09-21
CA2727576C (fr) 2016-08-16
IL209625A (en) 2015-11-30
AU2009254550B2 (en) 2013-10-24
SI3150227T1 (sl) 2019-02-28
WO2009147214A2 (fr) 2009-12-10
EP2300054A2 (fr) 2011-03-30
CN102056628B (zh) 2013-07-10
HUE030669T2 (en) 2017-05-29
EP2130553A1 (fr) 2009-12-09
EP3150227B1 (fr) 2018-10-31
EP3150227A1 (fr) 2017-04-05
MX2010013322A (es) 2011-01-21
ES2602048T3 (es) 2017-02-17
CY1118217T1 (el) 2017-06-28
AU2009254550A1 (en) 2009-12-10
HRP20161465T1 (hr) 2017-01-27
PT3150227T (pt) 2018-12-24
HRP20181993T1 (hr) 2019-01-25
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
LT2300054T (lt) 2016-12-27
MA32453B1 (fr) 2011-07-03
CA2727576A1 (fr) 2009-12-10
EA023012B1 (ru) 2016-04-29
JP5734181B2 (ja) 2015-06-17
PL2300054T3 (pl) 2017-04-28
ES2702249T3 (es) 2019-02-28
DK2300054T3 (en) 2016-12-05
SG10201405288WA (en) 2014-10-30
CY1121078T1 (el) 2019-12-11
US8845507B2 (en) 2014-09-30
EP2300054B1 (fr) 2016-09-07
SI2300054T1 (sl) 2017-02-28
KR20110028616A (ko) 2011-03-21
KR101639281B1 (ko) 2016-07-13
JP2011524866A (ja) 2011-09-08

Similar Documents

Publication Publication Date Title
HRP20161465T8 (hr) Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
SMT201900049T1 (it) Composti eterociclici e loro utilizzi
PL3395876T3 (pl) Nowe nanocząstki
EP2401367A4 (fr) Transposases piggybac hyperactives
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
EP3988147C0 (fr) Ensemble d'insertion
BRPI0907884A2 (pt) Partícula de liberação
BRPI0909220A2 (pt) Partícula de liberação
EP2306992A4 (fr) Particule de vectorisation
FR2929464B1 (fr) Nano resonnateur magnetique
EP2264681A4 (fr) Alarme
HUE044194T2 (hu) Besugárzó berendezés
EP2486509A4 (fr) Sécurité de plateforme
EP2256707A4 (fr) Alarme
EP2387787A4 (fr) Nanoparticules magnétiques
EP2300238A4 (fr) Caractéristique de sécurité sous la forme d'une image fantôme
DE502009000614D1 (de) Anhängekupplung
EP2429699A4 (fr) Modification de la densité
EP2350385A4 (fr) Section de mise en forme
DK2506831T3 (da) Carboxyvinylpolymerholdige nanopartikelsuspensioner
SMT201500273B (it) Diidroetorfine e loro preparazione
DK2329319T3 (da) Forbedret nanoimprint fremgangsmåde
EP2288449A4 (fr) Nanoparticules hybrides
DK2277578T3 (da) Forstøver
ITBO20080033A1 (it) Tutore